Skip to main content

Ensign Peak Advisors, Inc

SEC CIK
0001454984
Latest filing
Aug 14, 2026

AMED holding history

Amedisys Inc in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMED overviewAll 13F holders of AMEDFull Q2 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
9
Since Q1 2021
Holdings of AMED by Ensign Peak Advisors, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−215,099−100.0%Sold outHolders
Q1 2023215,099$15.8M<0.1%−101,207−32.0%ReducedHolders
Q4 2022316,306$26.4M0.1%−251,801−44.3%ReducedHolders
Q3 2022568,107$55.0M0.1%−4,491−0.8%ReducedHolders
Q2 2022572,598$60.2M0.1%+357,598+166.3%AddedHolders
Q1 2022215,000$37.0M0.1%−39,258−15.4%ReducedHolders
Q4 2021254,258$41.2M0.1%−17,184−6.3%ReducedHolders
Q3 2021271,442$40.5M0.1%+109,218+67.3%AddedHolders
Q2 2021162,224$39.7M0.1%+88,374+119.7%AddedHolders
Q1 202173,850$19.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.